Last reviewed · How we verify
Amlodipine 5mg, Candesartan cilexetil 16mg
Amlodipine 5mg, Candesartan cilexetil 16mg is a Small molecule drug developed by HK inno.N Corporation. It is currently in Phase 3 development. Also known as: Novarsc 5mg, Atacand 16mg.
At a glance
| Generic name | Amlodipine 5mg, Candesartan cilexetil 16mg |
|---|---|
| Also known as | Novarsc 5mg, Atacand 16mg |
| Sponsor | HK inno.N Corporation |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
- Headache
- Dizziness
- Edema
- Fatigue
- Rash
- Cough
- General Pain
- Palpitation
- Frequent urination
- Falling
- Runny nose
- Nausea
Key clinical trials
- Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial Hypertension (PHASE3)
- A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy (PHASE3)
- CAndesartan vs LIsinopril Effects on the BRain (PHASE2)
- Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy (PHASE3)
- Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan (PHASE4)
- Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension (PHASE2)
- Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B (PHASE1)
- Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Amlodipine 5mg, Candesartan cilexetil 16mg CI brief — competitive landscape report
- Amlodipine 5mg, Candesartan cilexetil 16mg updates RSS · CI watch RSS
- HK inno.N Corporation portfolio CI
Frequently asked questions about Amlodipine 5mg, Candesartan cilexetil 16mg
What is Amlodipine 5mg, Candesartan cilexetil 16mg?
Amlodipine 5mg, Candesartan cilexetil 16mg is a Small molecule drug developed by HK inno.N Corporation.
Who makes Amlodipine 5mg, Candesartan cilexetil 16mg?
Amlodipine 5mg, Candesartan cilexetil 16mg is developed by HK inno.N Corporation (see full HK inno.N Corporation pipeline at /company/hk-inno-n-corporation).
Is Amlodipine 5mg, Candesartan cilexetil 16mg also known as anything else?
Amlodipine 5mg, Candesartan cilexetil 16mg is also known as Novarsc 5mg, Atacand 16mg.
What development phase is Amlodipine 5mg, Candesartan cilexetil 16mg in?
Amlodipine 5mg, Candesartan cilexetil 16mg is in Phase 3.
What are the side effects of Amlodipine 5mg, Candesartan cilexetil 16mg?
Common side effects of Amlodipine 5mg, Candesartan cilexetil 16mg include Headache, Dizziness, Edema, Fatigue, Rash, Cough.
Related
- Manufacturer: HK inno.N Corporation — full pipeline
- Also known as: Novarsc 5mg, Atacand 16mg
- Compare: Amlodipine 5mg, Candesartan cilexetil 16mg vs similar drugs
- Pricing: Amlodipine 5mg, Candesartan cilexetil 16mg cost, discount & access